-
公开(公告)号:US20110082116A1
公开(公告)日:2011-04-07
申请号:US12967282
申请日:2010-12-14
申请人: William A. Carroll , Michael J. Dart , Teodozyj Kolasa , Tongmei Li , Derek W. Nelson , Meena V. Patel , Sridhar Peddi , Arturo Perez-Medrano , Xueqing Wang
发明人: William A. Carroll , Michael J. Dart , Teodozyj Kolasa , Tongmei Li , Derek W. Nelson , Meena V. Patel , Sridhar Peddi , Arturo Perez-Medrano , Xueqing Wang
IPC分类号: A61K31/655 , A61K31/425 , A61K31/429 , A61K31/5377 , A61K31/427 , A61K31/4439 , A61K31/4709 , A61P29/00 , A61P37/00 , A61P9/00 , A61P35/00 , A61P11/00
CPC分类号: A61K31/425 , A61K31/427 , A61K31/429 , A61K31/4436 , A61K31/4725 , A61K31/5377 , C07D275/02 , C07D275/04 , C07D417/04 , C07D417/06 , C07D417/12 , C07D513/04 , C07D513/10 , Y02P20/582
摘要: The present application relates to isothiazolylidene containing compounds of Formula (I) wherein R1, R2, R3, R4, and L are as defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
摘要翻译: 本申请涉及含有异噻唑基的式(I)化合物,其中R 1,R 2,R 3,R 4和L如说明书中所定义,包含这些化合物的组合物,以及使用这些化合物和组合物治疗病症和障碍的方法。
-
公开(公告)号:US07872033B2
公开(公告)日:2011-01-18
申请号:US12100731
申请日:2008-04-10
申请人: William A. Carroll , Michael J. Dart , Teodozyj Kolasa , Tongmei Li , Derek W. Nelson , Meena V. Patel , Sridhar Peddi , Arturo Perez-Medrano , Xueqing Wang
发明人: William A. Carroll , Michael J. Dart , Teodozyj Kolasa , Tongmei Li , Derek W. Nelson , Meena V. Patel , Sridhar Peddi , Arturo Perez-Medrano , Xueqing Wang
IPC分类号: C07D417/12 , C07D417/06 , C07D275/03 , C07D275/04 , A61K31/5377 , A61K31/4725 , A61K31/4436 , A61K31/4178 , A61K31/4155 , A61K31/416 , A61K31/4162 , A61K31/415
CPC分类号: A61K31/425 , A61K31/427 , A61K31/429 , A61K31/4436 , A61K31/4725 , A61K31/5377 , C07D275/02 , C07D275/04 , C07D417/04 , C07D417/06 , C07D417/12 , C07D513/04 , C07D513/10 , Y02P20/582
摘要: The present application relates to isothiazolylidene containing compounds of Formula (I) wherein R1, R2, R3, R4, and L are as defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
摘要翻译: 本申请涉及含有异噻唑基的式(I)化合物,其中R 1,R 2,R 3,R 4和L如说明书中所定义,包含这些化合物的组合物,以及使用这些化合物和组合物治疗病症和障碍的方法。
-
公开(公告)号:US20100249129A1
公开(公告)日:2010-09-30
申请号:US12732421
申请日:2010-03-26
申请人: William A. Carroll , Michael J. Dart , Jennifer M. Frost , Steven P. Latshaw , Tongmei Li , Bo Liu , Sridhar Peddi , Xueqing Wang , Teodozyj Kolasa , Derek W. Nelson , Arturo Perez-Medrano
发明人: William A. Carroll , Michael J. Dart , Jennifer M. Frost , Steven P. Latshaw , Tongmei Li , Bo Liu , Sridhar Peddi , Xueqing Wang , Teodozyj Kolasa , Derek W. Nelson , Arturo Perez-Medrano
IPC分类号: A61K31/433 , C07D417/08 , C07D417/06 , C07D405/06 , A61K31/443 , C07D413/06 , A61K31/422 , A61K31/4025 , A61K31/403 , C07D405/14 , C07D413/14 , A61K31/5377 , A61P29/00 , A61P25/00 , A61P37/02 , A61P11/00 , A61P35/00 , A61P9/00
CPC分类号: C07D417/06 , C07D405/06 , C07D413/06
摘要: Disclosed herein are compounds of formula (I) wherein Ring A and R1 are as defined in the specification. Pharmaceutical compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and pharmaceutical compositions are also disclosed.
摘要翻译: 本文公开了式(I)的化合物,其中环A和R 1如说明书中所定义。 还公开了包含这些化合物的药物组合物,以及使用这些化合物和药物组合物治疗病症和障碍的方法。
-
公开(公告)号:US20100216760A1
公开(公告)日:2010-08-26
申请号:US12639173
申请日:2009-12-16
申请人: Jennifer M. Frost , Steven P. Latshaw , Michael J. Dart , William A. Carroll , Arturo Perez-Medrano , Teodozyj Kolasa , Meena V. Patel , Derek W. Nelson , Tongmei Li , Sridhar Peddi , Xueqing Wang , Bo Liu
发明人: Jennifer M. Frost , Steven P. Latshaw , Michael J. Dart , William A. Carroll , Arturo Perez-Medrano , Teodozyj Kolasa , Meena V. Patel , Derek W. Nelson , Tongmei Li , Sridhar Peddi , Xueqing Wang , Bo Liu
IPC分类号: A61K31/427 , C07D417/12 , C07D471/04 , A61K31/437 , A61P29/00
CPC分类号: C07D417/12 , C07D277/46 , C07D513/04
摘要: Disclosed herein are cannabinoid receptor ligands of formula (I) wherein L1, A1, R1g, z, R2, R3, and R4 are as defined in the specification. Compositions comprising such compounds and methods for treating conditions and disorders using such compounds and compositions are also presented.
摘要翻译: 本文公开了式(I)的大麻素受体配体,其中L1,A1,R1g,z,R2,R3和R4如说明书中所定义。 还提出了包含这些化合物的组合物和使用这些化合物和组合物治疗病症和障碍的方法。
-
公开(公告)号:US20100069349A1
公开(公告)日:2010-03-18
申请号:US12560897
申请日:2009-09-16
申请人: William A. Carroll , Michael J. Dart , Jennifer M. Frost , Steven P. Latshaw , Teodozyj Kolasa , Tongmei Li , Sridhar Peddi , Bo Liu , Arturo Perez-Medrano , Meena Patel , Xueqing Wang , Derek W. Nelson
发明人: William A. Carroll , Michael J. Dart , Jennifer M. Frost , Steven P. Latshaw , Teodozyj Kolasa , Tongmei Li , Sridhar Peddi , Bo Liu , Arturo Perez-Medrano , Meena Patel , Xueqing Wang , Derek W. Nelson
IPC分类号: A61K31/397 , C07D207/30 , C07D285/12 , A61K31/40 , A61P3/10 , A61P9/10 , A61P25/00
CPC分类号: C07D405/12 , C07D231/40 , C07D285/135 , C07D403/12 , C07D405/14 , C07D409/14 , C07D413/12 , C07D413/14 , C07D417/12
摘要: Disclosed herein are cannabinoid receptor ligands of formula (I) wherein A1, A5, Rx, X4, and z are as defined in the specification. Compositions comprising such compounds, and methods for treating conditions and disorders using such compounds and compositions are also disclosed.
摘要翻译: 本文公开了式(I)的大麻素受体配体,其中A1,A5,Rx,X4和z如说明书中所定义。 还公开了包含这些化合物的组合物,以及使用这些化合物和组合物治疗病症和障碍的方法。
-
46.
公开(公告)号:US20080153883A1
公开(公告)日:2008-06-26
申请号:US11954956
申请日:2007-12-12
IPC分类号: A61K31/4439 , A61K31/426 , C07D417/02 , C07D277/02 , A61P35/00 , A61P25/28
CPC分类号: C07D277/18 , C07D417/06 , C07D417/12 , C07D417/14
摘要: The present invention relates to thiazolidinylidene containing compounds of formula (I) wherein R1, R2, R3, R4, R5, R6, and X are as defined in the specification, compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
摘要翻译: 本发明涉及含有噻唑烷亚基的式(I)化合物,其中R 1,R 2,R 3,R 4, R 5,R 6和X如说明书中所定义,包含这些化合物的组合物,以及使用这些化合物和组合物治疗病症和障碍的方法 。
-
-
-
-
-